Global Gastric Cancer Drugs Market Insights and Forecast to 2028

Report ID: 1380338 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Gastric Cancer Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Gastric Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Doxorubicin Hydrochloride
        1.2.3 Sunitinib
        1.2.4 Docetaxel
        1.2.5 Mitomycin
        1.2.6 Fluorouracil
        1.2.7 Imatinib
        1.2.8 Trastuzumab
    1.3 Market by Application
        1.3.1 Global Gastric Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Gastric Cancer Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Gastric Cancer Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Gastric Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Gastric Cancer Drugs Sales by Region
        2.4.1 Global Gastric Cancer Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Gastric Cancer Drugs by Region (2023-2028)
    2.5 Global Gastric Cancer Drugs Revenue by Region
        2.5.1 Global Gastric Cancer Drugs Revenue by Region (2017-2022)
        2.5.2 Global Gastric Cancer Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gastric Cancer Drugs Sales by Manufacturers
        3.1.1 Global Top Gastric Cancer Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Gastric Cancer Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastric Cancer Drugs in 2021
    3.2 Global Gastric Cancer Drugs Revenue by Manufacturers
        3.2.1 Global Gastric Cancer Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Gastric Cancer Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Gastric Cancer Drugs Revenue in 2021
    3.3 Global Gastric Cancer Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gastric Cancer Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Gastric Cancer Drugs Sales by Type
        4.1.1 Global Gastric Cancer Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Gastric Cancer Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Gastric Cancer Drugs Revenue by Type
        4.2.1 Global Gastric Cancer Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Gastric Cancer Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Gastric Cancer Drugs Price by Type
        4.3.1 Global Gastric Cancer Drugs Price by Type (2017-2022)
        4.3.2 Global Gastric Cancer Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Gastric Cancer Drugs Sales by Application
        5.1.1 Global Gastric Cancer Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Gastric Cancer Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Gastric Cancer Drugs Revenue by Application
        5.2.1 Global Gastric Cancer Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Gastric Cancer Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Gastric Cancer Drugs Price by Application
        5.3.1 Global Gastric Cancer Drugs Price by Application (2017-2022)
        5.3.2 Global Gastric Cancer Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Gastric Cancer Drugs Market Size by Type
        6.1.1 North America Gastric Cancer Drugs Sales by Type (2017-2028)
        6.1.2 North America Gastric Cancer Drugs Revenue by Type (2017-2028)
    6.2 North America Gastric Cancer Drugs Market Size by Application
        6.2.1 North America Gastric Cancer Drugs Sales by Application (2017-2028)
        6.2.2 North America Gastric Cancer Drugs Revenue by Application (2017-2028)
    6.3 North America Gastric Cancer Drugs Market Size by Country
        6.3.1 North America Gastric Cancer Drugs Sales by Country (2017-2028)
        6.3.2 North America Gastric Cancer Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Gastric Cancer Drugs Market Size by Type
        7.1.1 Europe Gastric Cancer Drugs Sales by Type (2017-2028)
        7.1.2 Europe Gastric Cancer Drugs Revenue by Type (2017-2028)
    7.2 Europe Gastric Cancer Drugs Market Size by Application
        7.2.1 Europe Gastric Cancer Drugs Sales by Application (2017-2028)
        7.2.2 Europe Gastric Cancer Drugs Revenue by Application (2017-2028)
    7.3 Europe Gastric Cancer Drugs Market Size by Country
        7.3.1 Europe Gastric Cancer Drugs Sales by Country (2017-2028)
        7.3.2 Europe Gastric Cancer Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gastric Cancer Drugs Market Size by Type
        8.1.1 Asia Pacific Gastric Cancer Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Gastric Cancer Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Gastric Cancer Drugs Market Size by Application
        8.2.1 Asia Pacific Gastric Cancer Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Gastric Cancer Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Gastric Cancer Drugs Market Size by Region
        8.3.1 Asia Pacific Gastric Cancer Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Gastric Cancer Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Gastric Cancer Drugs Market Size by Type
        9.1.1 Latin America Gastric Cancer Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Gastric Cancer Drugs Revenue by Type (2017-2028)
    9.2 Latin America Gastric Cancer Drugs Market Size by Application
        9.2.1 Latin America Gastric Cancer Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Gastric Cancer Drugs Revenue by Application (2017-2028)
    9.3 Latin America Gastric Cancer Drugs Market Size by Country
        9.3.1 Latin America Gastric Cancer Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Gastric Cancer Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Gastric Cancer Drugs Market Size by Type
        10.1.1 Middle East and Africa Gastric Cancer Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Gastric Cancer Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Gastric Cancer Drugs Market Size by Application
        10.2.1 Middle East and Africa Gastric Cancer Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Gastric Cancer Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Gastric Cancer Drugs Market Size by Country
        10.3.1 Middle East and Africa Gastric Cancer Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Gastric Cancer Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 Eli Lilly
        11.2.1 Eli Lilly Corporation Information
        11.2.2 Eli Lilly Overview
        11.2.3 Eli Lilly Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Eli Lilly Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Eli Lilly Recent Developments
    11.3 F. Hoffmann-La Roche
        11.3.1 F. Hoffmann-La Roche Corporation Information
        11.3.2 F. Hoffmann-La Roche Overview
        11.3.3 F. Hoffmann-La Roche Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 F. Hoffmann-La Roche Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 F. Hoffmann-La Roche Recent Developments
    11.4 Otsuka Pharmaceutical
        11.4.1 Otsuka Pharmaceutical Corporation Information
        11.4.2 Otsuka Pharmaceutical Overview
        11.4.3 Otsuka Pharmaceutical Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Otsuka Pharmaceutical Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Otsuka Pharmaceutical Recent Developments
    11.5 Novartis
        11.5.1 Novartis Corporation Information
        11.5.2 Novartis Overview
        11.5.3 Novartis Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Novartis Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Novartis Recent Developments
    11.6 Amgen
        11.6.1 Amgen Corporation Information
        11.6.2 Amgen Overview
        11.6.3 Amgen Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Amgen Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Amgen Recent Developments
    11.7 Merck
        11.7.1 Merck Corporation Information
        11.7.2 Merck Overview
        11.7.3 Merck Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Merck Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Corporation Information
        11.8.2 AstraZeneca Overview
        11.8.3 AstraZeneca Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AstraZeneca Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AstraZeneca Recent Developments
    11.9 Boehringer Ingelheim
        11.9.1 Boehringer Ingelheim Corporation Information
        11.9.2 Boehringer Ingelheim Overview
        11.9.3 Boehringer Ingelheim Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Boehringer Ingelheim Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Boehringer Ingelheim Recent Developments
    11.10 Daiichi-Sankyo
        11.10.1 Daiichi-Sankyo Corporation Information
        11.10.2 Daiichi-Sankyo Overview
        11.10.3 Daiichi-Sankyo Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Daiichi-Sankyo Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Daiichi-Sankyo Recent Developments
    11.11 Bayer HealthCare
        11.11.1 Bayer HealthCare Corporation Information
        11.11.2 Bayer HealthCare Overview
        11.11.3 Bayer HealthCare Gastric Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Bayer HealthCare Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Bayer HealthCare Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Gastric Cancer Drugs Industry Chain Analysis
    12.2 Gastric Cancer Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gastric Cancer Drugs Production Mode & Process
    12.4 Gastric Cancer Drugs Sales and Marketing
        12.4.1 Gastric Cancer Drugs Sales Channels
        12.4.2 Gastric Cancer Drugs Distributors
    12.5 Gastric Cancer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gastric Cancer Drugs Industry Trends
    13.2 Gastric Cancer Drugs Market Drivers
    13.3 Gastric Cancer Drugs Market Challenges
    13.4 Gastric Cancer Drugs Market Restraints
14 Key Findings in The Global Gastric Cancer Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Gastric Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Doxorubicin Hydrochloride
    Table 3. Major Manufacturers of Sunitinib
    Table 4. Major Manufacturers of Docetaxel
    Table 5. Major Manufacturers of Mitomycin
    Table 6. Major Manufacturers of Fluorouracil
    Table 7. Major Manufacturers of Imatinib
    Table 8. Major Manufacturers of Trastuzumab
    Table 9. Global Gastric Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Gastric Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Gastric Cancer Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 12. Global Gastric Cancer Drugs Sales Market Share by Region (2017-2022)
    Table 13. Global Gastric Cancer Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 14. Global Gastric Cancer Drugs Sales Market Share by Region (2023-2028)
    Table 15. Global Gastric Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Gastric Cancer Drugs Revenue Market Share by Region (2017-2022)
    Table 17. Global Gastric Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Gastric Cancer Drugs Revenue Market Share by Region (2023-2028)
    Table 19. Global Gastric Cancer Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 20. Global Gastric Cancer Drugs Sales Share by Manufacturers (2017-2022)
    Table 21. Global Gastric Cancer Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Gastric Cancer Drugs Revenue Share by Manufacturers (2017-2022)
    Table 23. Gastric Cancer Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 24. Global Gastric Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Gastric Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Cancer Drugs as of 2021)
    Table 26. Gastric Cancer Drugs Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Gastric Cancer Drugs Product Offered
    Table 28. Date of Manufacturers Enter into Gastric Cancer Drugs Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 31. Global Gastric Cancer Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 32. Global Gastric Cancer Drugs Sales Share by Type (2017-2022)
    Table 33. Global Gastric Cancer Drugs Sales Share by Type (2023-2028)
    Table 34. Global Gastric Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Gastric Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Gastric Cancer Drugs Revenue Share by Type (2017-2022)
    Table 37. Global Gastric Cancer Drugs Revenue Share by Type (2023-2028)
    Table 38. Gastric Cancer Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 39. Global Gastric Cancer Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 40. Global Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 41. Global Gastric Cancer Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 42. Global Gastric Cancer Drugs Sales Share by Application (2017-2022)
    Table 43. Global Gastric Cancer Drugs Sales Share by Application (2023-2028)
    Table 44. Global Gastric Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Gastric Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Gastric Cancer Drugs Revenue Share by Application (2017-2022)
    Table 47. Global Gastric Cancer Drugs Revenue Share by Application (2023-2028)
    Table 48. Gastric Cancer Drugs Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Global Gastric Cancer Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 50. North America Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 51. North America Gastric Cancer Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 52. North America Gastric Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Gastric Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 55. North America Gastric Cancer Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 56. North America Gastric Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Gastric Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 59. North America Gastric Cancer Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 60. North America Gastric Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Gastric Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 63. Europe Gastric Cancer Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 64. Europe Gastric Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Gastric Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 67. Europe Gastric Cancer Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 68. Europe Gastric Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Gastric Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 71. Europe Gastric Cancer Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 72. Europe Gastric Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Gastric Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 75. Asia Pacific Gastric Cancer Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 76. Asia Pacific Gastric Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Gastric Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 79. Asia Pacific Gastric Cancer Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 80. Asia Pacific Gastric Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Gastric Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Gastric Cancer Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 83. Asia Pacific Gastric Cancer Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 84. Asia Pacific Gastric Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Gastric Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 87. Latin America Gastric Cancer Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 88. Latin America Gastric Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Gastric Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 91. Latin America Gastric Cancer Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 92. Latin America Gastric Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Gastric Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 95. Latin America Gastric Cancer Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 96. Latin America Gastric Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Gastric Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 99. Middle East and Africa Gastric Cancer Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 100. Middle East and Africa Gastric Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Gastric Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 103. Middle East and Africa Gastric Cancer Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 104. Middle East and Africa Gastric Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Gastric Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 107. Middle East and Africa Gastric Cancer Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 108. Middle East and Africa Gastric Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Gastric Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Major Businesses
    Table 112. Sanofi Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 113. Sanofi Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Sanofi Recent Developments
    Table 115. Eli Lilly Corporation Information
    Table 116. Eli Lilly Description and Major Businesses
    Table 117. Eli Lilly Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 118. Eli Lilly Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Eli Lilly Recent Developments
    Table 120. F. Hoffmann-La Roche Corporation Information
    Table 121. F. Hoffmann-La Roche Description and Major Businesses
    Table 122. F. Hoffmann-La Roche Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 123. F. Hoffmann-La Roche Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. F. Hoffmann-La Roche Recent Developments
    Table 125. Otsuka Pharmaceutical Corporation Information
    Table 126. Otsuka Pharmaceutical Description and Major Businesses
    Table 127. Otsuka Pharmaceutical Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 128. Otsuka Pharmaceutical Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Otsuka Pharmaceutical Recent Developments
    Table 130. Novartis Corporation Information
    Table 131. Novartis Description and Major Businesses
    Table 132. Novartis Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 133. Novartis Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Novartis Recent Developments
    Table 135. Amgen Corporation Information
    Table 136. Amgen Description and Major Businesses
    Table 137. Amgen Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 138. Amgen Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Amgen Recent Developments
    Table 140. Merck Corporation Information
    Table 141. Merck Description and Major Businesses
    Table 142. Merck Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 143. Merck Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Merck Recent Developments
    Table 145. AstraZeneca Corporation Information
    Table 146. AstraZeneca Description and Major Businesses
    Table 147. AstraZeneca Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 148. AstraZeneca Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. AstraZeneca Recent Developments
    Table 150. Boehringer Ingelheim Corporation Information
    Table 151. Boehringer Ingelheim Description and Major Businesses
    Table 152. Boehringer Ingelheim Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 153. Boehringer Ingelheim Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Boehringer Ingelheim Recent Developments
    Table 155. Daiichi-Sankyo Corporation Information
    Table 156. Daiichi-Sankyo Description and Major Businesses
    Table 157. Daiichi-Sankyo Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 158. Daiichi-Sankyo Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Daiichi-Sankyo Recent Developments
    Table 160. Bayer HealthCare Corporation Information
    Table 161. Bayer HealthCare Description and Major Businesses
    Table 162. Bayer HealthCare Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 163. Bayer HealthCare Gastric Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Bayer HealthCare Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Gastric Cancer Drugs Distributors List
    Table 168. Gastric Cancer Drugs Customers List
    Table 169. Gastric Cancer Drugs Market Trends
    Table 170. Gastric Cancer Drugs Market Drivers
    Table 171. Gastric Cancer Drugs Market Challenges
    Table 172. Gastric Cancer Drugs Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastric Cancer Drugs Product Picture
    Figure 3. Global Gastric Cancer Drugs Market Share by Type in 2021 & 2028
    Figure 3. Doxorubicin Hydrochloride Product Picture
    Figure 4. Sunitinib Product Picture
    Figure 5. Docetaxel Product Picture
    Figure 6. Mitomycin Product Picture
    Figure 7. Fluorouracil Product Picture
    Figure 8. Imatinib Product Picture
    Figure 9. Trastuzumab Product Picture
    Figure 10. Global Gastric Cancer Drugs Market Share by Application in 2021 & 2028
    Figure 11. Hospitals
    Figure 12. Clinics
    Figure 13. Other
    Figure 14. Gastric Cancer Drugs Report Years Considered
    Figure 15. Global Gastric Cancer Drugs Sales 2017-2028 (K Pcs)
    Figure 16. Global Gastric Cancer Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Gastric Cancer Drugs Revenue 2017-2028 (US$ Million)
    Figure 18. Global Gastric Cancer Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Gastric Cancer Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Gastric Cancer Drugs Sales Market Share by Region (2023-2028)
    Figure 21. North America Gastric Cancer Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 22. North America Gastric Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Gastric Cancer Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Europe Gastric Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Gastric Cancer Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Asia-Pacific Gastric Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Gastric Cancer Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Latin America Gastric Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Gastric Cancer Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 30. Middle East & Africa Gastric Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Gastric Cancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Gastric Cancer Drugs in the World: Market Share by Gastric Cancer Drugs Revenue in 2021
    Figure 33. Global Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 35. Global Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. Global Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 37. Global Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 40. North America Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 41. North America Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 42. North America Gastric Cancer Drugs Sales Share by Country (2017-2028)
    Figure 43. North America Gastric Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 44. U.S. Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 47. Europe Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 49. Europe Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Gastric Cancer Drugs Sales Share by Country (2017-2028)
    Figure 51. Europe Gastric Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 52. Germany Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. France Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Gastric Cancer Drugs Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Gastric Cancer Drugs Revenue Share by Region (2017-2028)
    Figure 63. China Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. India Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Gastric Cancer Drugs Sales Share by Country (2017-2028)
    Figure 78. Latin America Gastric Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 79. Mexico Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Gastric Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Gastric Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Gastric Cancer Drugs Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Gastric Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 88. Turkey Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Gastric Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 91. Gastric Cancer Drugs Value Chain
    Figure 92. Gastric Cancer Drugs Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Eli Lilly
F. Hoffmann-La Roche
Otsuka Pharmaceutical
Novartis
Amgen
Merck
AstraZeneca
Boehringer Ingelheim
Daiichi-Sankyo
Bayer HealthCare
Frequently Asked Questions
Gastric Cancer Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastric Cancer Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastric Cancer Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Videoscopes

Medical Videoscopes market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Dental Consumables

Dental Consumables market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More